NCT02142959 2025-06-03
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Biogen
Phase 2 Completed
Clinical Trials
6 trialsNCT04261387 2022-07-27
LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients
Lutris Pharma Ltd.
Phase 1/2 Completed
NCT03988556 2021-04-30
SafePBM
NeoMedLight
Phase NA Completed
NCT03255980 2020-12-16
Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®
Helsinn Healthcare SA
Phase NA Completed
NCT01714973 2019-05-13
Study of ST266 Versus Saline in Treating Skin Irritation From Radiation
Noveome Biotherapeutics, formerly Stemnion
Phase 1 Completed
NCT01513278 2013-07-15
Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer
Apeiron Biologics
Phase 1/2 Completed